IMARC Group’s report titled “Coronary Stents Market Report by Type (Drug-eluting Stents, Bare-metal Coronary Stents, Bioabsorbable Stents), Biomaterial (Metallic Biomaterial, Polymeric Biomaterial, Natural Biomaterial), Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2025-2033”. The global coronary stents market size reached USD 11.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.9 Billion by 2033, exhibiting a growth rate (CAGR) of 5.18% during 2025-2033.

Factors Affecting the Growth of the Coronary Stents Industry:

  • Increasing Prevalence of Cardiovascular Diseases:

More people developing heart conditions and CAD means more patients need medical procedures like angioplasty and stenting to restore their heart's normal blood flow. When doctors use stents to clear blocked heart arteries during medical treatments for CVD, the connection is clear: treat more heart patients, need more stents. More heart conditions bring attention to stopping heart disease before medical procedures become necessary. For most people nowadays, having a stent is becoming a common step before dangerous heart attacks can develop.

  • Technological Advancements:

The new "smart" stents that give off medicine are helping treat people better when they get heart problem surgery. The stents let medicine flow out to stay inside the artery wall, stopping it from clogging up again - which happens often with regular stents. The market grows because new drugs and delivery methods help improve results without requiring multiple procedures. The material science industry is making more flexible stents that match blood vessel shapes better and are less likely to break. Increased safety and effectiveness of stents help more doctors and patients choose them.

  • Growing Aging Population:

As people age, the risk of developing cardiovascular conditions such as coronary artery disease is increasing due to factors such as the natural aging of the vascular system and the increasing prevalence of risk factors such as hypertension, diabetes, and high cholesterol. Since coronary stents are a leading treatment option for managing these diseases, the growing aging population is directly catalyzing the demand for these devices. In addition, older adults typically require more medical care, including more frequent and intensive cardiac treatments. This demographic utilizes a greater volume of healthcare services, including angioplasty, where stents are used, driving the market demand.

Grab a sample PDF of this report: https://www.imarcgroup.com/coronary-stents-market/requestsample

Leading Companies Operating in the Global Coronary Stents Industry:

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Lepu Medical Technology (Beijing) Co. Ltd.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Terumo Corporation
  • Translumina GmbH.

Coronary Stents Market Report Segmentation:

By Type:

  • Drug-eluting Stents
  • Bare-metal Coronary Stents
  • Bioabsorbable Stents

Drug-eluting stents represent the largest segment due to their superior clinical outcomes compared to other types of stents.

By Biomaterial:

  • Metallic Biomaterial
  • Polymeric Biomaterial
  • Natural Biomaterial

Metallic biomaterial accounts for the majority of the market share owing to its exceptional mechanical properties, biocompatibility, and proven clinical efficacy.

By Mode of Delivery:

  • Balloon-expandable Stents
  • Self-expanding Stents

Self-expanding stents hold the biggest market share as their flexibility and ability to conform to the natural contours of the blood vessels make them particularly effective in treating complex lesions and tortuous anatomies.

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Hospitals exhibit a clear dominance in the market, driven by comprehensive care provided by them, including preoperative, perioperative, and postoperative management.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America enjoys the leading position in the coronary stents market on account of a high prevalence of cardiovascular diseases.

Global Coronary Stents Market Trends:

Enhancements in imaging technologies, such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS), allow for better placement and assessment of stents, ensuring that procedures are more successful and reducing complications. This technological synergy not only expands the effectiveness of stents but also drives their adoption by providing more confidence in procedural outcomes.

In addition, the integration of coronary stents with digital health technologies, including remote monitoring and real-time data analytics, enhances patient management post-implantation. This integration helps in monitoring stent performance and patient health, potentially alerting healthcare providers to issues before they become severe, thereby improving long-term outcomes.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact US

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145